Skinvisible Statistics
Total Valuation
Skinvisible has a market cap or net worth of $3.13 million. The enterprise value is $9.31 million.
Market Cap | 3.13M |
Enterprise Value | 9.31M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Skinvisible has 4.54 million shares outstanding.
Shares Outstanding | 4.54M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 4.20% |
Owned by Institutions (%) | n/a |
Float | 4.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 156.62 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 465.48 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.45 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -754.72% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $10,000 |
Profits Per Employee | -$578,878 |
Employee Count | 2 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Skinvisible has paid $335,287 in taxes.
Income Tax | 335,287 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +750.80% in the last 52 weeks. The beta is 0.15, so Skinvisible's price volatility has been lower than the market average.
Beta (5Y) | 0.15 |
52-Week Price Change | +750.80% |
50-Day Moving Average | 0.47 |
200-Day Moving Average | 0.17 |
Relative Strength Index (RSI) | 57.01 |
Average Volume (20 Days) | 1,117 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Skinvisible had revenue of $20,000 and -$1.16 million in losses. Loss per share was -$0.26.
Revenue | 20,000 |
Gross Profit | 1,178 |
Operating Income | -485,653 |
Pretax Income | -1.16M |
Net Income | -1.16M |
EBITDA | -466,823 |
EBIT | -485,645 |
Loss Per Share | -$0.26 |
Balance Sheet
The company has $8,097 in cash and $6.19 million in debt, giving a net cash position of -$6.18 million or -$1.36 per share.
Cash & Cash Equivalents | 8,097 |
Total Debt | 6.19M |
Net Cash | -6.18M |
Net Cash Per Share | -$1.36 |
Equity (Book Value) | -9.31M |
Book Value Per Share | -2.05 |
Working Capital | -4.06M |
Cash Flow
In the last 12 months, operating cash flow was -$37,733 and capital expenditures $525, giving a free cash flow of -$37,208.
Operating Cash Flow | -37,733 |
Capital Expenditures | 525 |
Free Cash Flow | -37,208 |
FCF Per Share | -$0.01 |
Margins
Gross margin is 5.89%, with operating and profit margins of -2,428.27% and -5,788.78%.
Gross Margin | 5.89% |
Operating Margin | -2,428.27% |
Pretax Margin | -5,788.78% |
Profit Margin | -5,788.78% |
EBITDA Margin | -2,334.12% |
EBIT Margin | -2,428.23% |
FCF Margin | -186.04% |
Dividends & Yields
Skinvisible does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -36.96% |
FCF Yield | -1.19% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 4, 2019. It was a reverse split with a ratio of 1:50.
Last Split Date | Jan 4, 2019 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Skinvisible has an Altman Z-Score of -403.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -403.95 |
Piotroski F-Score | 2 |